EUROPEAN CYSTIC FIBROSIS SOCIETY - 
Ranking results:
Past rankings:
| 2018 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2015 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Ranking timeline:
Project Participation Performance(2015-01-01 - 2024-12-31 ):
Total Project Funding:
Funding per Partner:
Projects:
Leadership:
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Summary:
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2018 | 0 | 79.715.114 | 701.960 | 3 | ||
| 2015 | 0 | 5.997.139 | 256.260 | 1 | ||
Networking:
Partners:
Constancy:
Total number of partners: 65
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 65
Frequent / Rare Partner Ratio: 0
Project overview:
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2018-05-01 | conect4children (COllaborative Network for European Clinical Trials For Children) | c4c | participant | 67.000.000 | 47 |
| 2018-01-01 | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | HIT-CF | participant | 6.701.365 | 10 |
| 2018-01-01 | A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis | OligoGpivotalCF | participant | 6.013.749 | 6 |
| 2015-05-01 | Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication | PRO-CF-MED | participant | 5.997.139 | 6 |